An emergency meeting will be held to discuss the Johnson & Johnson COVID-19 vaccine after six people developed blood clots from the shot.
An emergency meeting will be held to discuss the Johnson & Johnson COVID-19 vaccine after six people developed blood clots from the shot.
On Friday, CDC advisers meet again to look into the Johnson & Johnson vaccine. It comes as the CDC and FDA review data involving..